The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

CUE FINANCIAL STATEMENTS

Cue Biopharma — balance sheet, income statement and cash flow trends

CUECue Biopharma

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-100 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue37.7 M $Gross Profit37.5 M $ · 100%Operating Income-98.6 M $ · -262%Pre-tax Income-163.6 M $ · -435%Net Income to Owners-164.1 M $ · -436%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue37.7 M $+354.4%
Gross Profit37.5 M $+353.0%
Operating Income-98.6 M $—
EBITDA-95.9 M $—
Net Income to Owners-164.1 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
050 M100 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets30.7 M
  • Equity2.3 M $8%
  • Current Liabilities21.2 M $69%
  • Long-term Liabilities7.2 M $23%

Key Figures

YoY change
Total Assets30.7 M $-24.6%
Total Liabilities28.4 M $+25.9%
Total Equity2.3 M $-87.3%
Cash & ST Investments17.4 M $-36.7%
Total Debt8.8 M $+15.4%
Net Debt-8.6 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0100 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-40 M-20 M0-50 M $Operating131 K $Investing39.8 M $Financing-10.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow-50 M $—
Capital Expenditures121 K $-32.8%
Free Cash Flow-50.2 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CUE

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.